当前位置: X-MOL 学术Neuro Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas.
Neuro-Oncology ( IF 16.4 ) Pub Date : 2020-05-05 , DOI: 10.1093/neuonc/noaa113
Denise Bernhardt 1, 2, 3 , Wolfgang Wick 4 , Stephanie E Weiss 5 , Arjun Sahgal 6 , Simon S Lo 7 , John H Suh 8 , Eric L Chang 9 , Matthew Foote 10 , James Perry 11 , Bernhard Meyer 12 , Peter Vajkoczy 13 , Patrick Y Wen 14 , Christoph Straube 1, 2, 3 , Steffi Pigorsch 1, 2, 3 , Jan J Wilkens 1 , Stephanie E Combs 1, 2, 3
Affiliation  

Because of the increased risk in cancer patients of developing complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), physicians have to balance the competing risks of the negative impact of the pandemic and the primary tumor disease. In this consensus statement, an international group of experts present mitigation strategies and treatment guidance for patients suffering from high grade gliomas (HGGs) during the coronavirus disease 2019 (COVID-19) pandemic.

中文翻译:


COVID-19 大流行期间的神经肿瘤学管理,重点关注 WHO III 级和 IV 级神经胶质瘤。



由于癌症患者出现由严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 引起的并发症的风险增加,医生必须平衡大流行和原发肿瘤疾病的负面影响的竞争风险。在这份共识声明中,一个国际专家组为 2019 年冠状病毒病 (COVID-19) 大流行期间患有高级别胶质瘤 (HGG) 的患者提出了缓解策略和治疗指南。
更新日期:2020-07-07
down
wechat
bug